A prodrug strategy for the oral delivery of a poorly soluble HCV NS5B thumb pocket 1 polymerase inhibitor using self-emulsifying drug delivery systems (SEDDS). Issue 2 (15th January 2015) - Beaulieu, Pierre L.
Graphical abstract